| 產品詳情 |
| Edit |   |
|---|
| Product Name | BioSim? Nivolumab (Opdivo?)(Human) ELISA Kit |
|---|
| Description | Nivolumab (Opdivo?) is a human immunoglobulin G4 (IgG4) monoclonal antibody that binds to the programmed cell death 1 (PD-1) receptor and selectively blocks interaction with its programmed death ligands PD-L1 and PD-L2. Upregulation of PD-1 ligands occurs in some tumors and signalling through this pathway can contribute to inhibition of active T-cell immune surveillance of tumour tissue. The inhibitory effect of PD-1 and its ligands occurs through the promotion of apoptosis in antigen specific T cells while simultaneously blocking apoptosis in suppressor T cells. Blocking PD-1 activity has been shown to lead to decreased tumour growth in mouse tumour models. BioSim? Nivolumab ELISA kit has been developed for specific quantificatio |
|---|
| Size | 100 assays |
|---|
| Concentration | n/a |
|---|
| Applications | This ELISA kit is used for quantitative measurement of Nivolumab in human serum and plasma |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | E4382-100 |
|---|
| Price | |
|---|
| Order / More Info | BioSim™ Nivolumab (Opdivo®)(Human) ELISA Kit from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產品資料 |
|
|